v3.26.1
WEIGHTED AVERAGE COMMON SHARES
3 Months Ended
Mar. 31, 2026
Weighted Average Common Shares  
WEIGHTED AVERAGE COMMON SHARES

NOTE 10 – WEIGHTED AVERAGE COMMON SHARES

 

The Company reported a net loss during the three month periods ended March 31, 2026 and 2025, as such, the inclusion of potentially dilutive securities in the computation of Diluted EPS would be anti-dilutive. Potentially dilutive securities excluded from the computation of diluted EPS was as follows:

 

          
   THREE MONTHS END 
   MARCH 31, 
   2026   2025 
   (Unaudited) 
         
Convertible Note (see Note 6)   22,176,009    319,342 
Series A Preferred (see Note 8)   5,000,000    5,000,000 
Series B preferred stock (see Note 8)   1,730,879    1,133,901 
Detachable common stock warrants (see Note 9)   400,000    400,000 
Total anti-dilutive securities excluded from diluted weighted average common shares   29,306,887    6,853,243 

 

The above potentially diluted securities were excluded from the calculation as the exercise prices were in excess of the fair market value of the Company’s common stock.